Composition À Base De Mycoplasma Gallisepticum
The present invention provides a formulation that prevents virulent Mycoplasma galHsepticum infection in birds of the order GaIHf ormes. The formulation comprises live Mycoplasma galHsepticum strain K5831 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulent Mycoplasma galHsepticum infection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.
Patents:WO 2,010,085,611
Inventor(s):
KLEVEN STANLEY H [US]; FERGUSON NAOLA M [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents